These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30067509)

  • 1. Chemotherapeutic resistance: a nano-mechanical point of view.
    Nyongesa CO; Park S
    Biol Chem; 2018 Nov; 399(12):1433-1446. PubMed ID: 30067509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical Alteration Associated With Chemotherapeutic Resistance of Breast Cancer Cells.
    Park S
    J Cancer Prev; 2018 Jun; 23(2):87-92. PubMed ID: 30003069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-mechanical reinforcement in drug-resistant ovarian cancer cells.
    Seo YH; Jo YN; Oh YJ; Park S
    Biol Pharm Bull; 2015; 38(3):389-95. PubMed ID: 25757920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.
    Gao Y; Shen JK; Milane L; Hornicek FJ; Amiji MM; Duan Z
    Curr Med Chem; 2015; 22(11):1335-47. PubMed ID: 25666804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance and apoptosis in cancer treatment: development of new apoptosis-inducing agents active in drug resistant malignancies.
    Tolomeo M; Simoni D
    Curr Med Chem Anticancer Agents; 2002 May; 2(3):387-401. PubMed ID: 12678739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells.
    Wang F; Chen Y; Huang L; Liu T; Huang Y; Zhao J; Wang X; Yang K; Ma S; Huang L; To KK; Gu Y; Fu L
    Oncotarget; 2015 Dec; 6(38):40850-65. PubMed ID: 26506420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stiffness changes of tumor HEp2 cells correlates with the inhibition and release of TRAIL-induced apoptosis pathways.
    Targosz-Korecka M; Biedron R; Szczygiel AM; Brzezinka G; Szczerbinski J; Zuk A
    J Mol Recognit; 2012 May; 25(5):299-308. PubMed ID: 22528192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Nano-Surface of Collagenous and Other Fibrotic Tissues with AFM.
    Stylianou A; Gkretsi V; Patrickios CS; Stylianopoulos T
    Methods Mol Biol; 2017; 1627():453-489. PubMed ID: 28836219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho GTPases: Promising candidates for overcoming chemotherapeutic resistance.
    Zheng CW; Zeng RJ; Xu LY; Li EM
    Cancer Lett; 2020 Apr; 475():65-78. PubMed ID: 31981606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products to prevent drug resistance in cancer chemotherapy: a review.
    Yuan R; Hou Y; Sun W; Yu J; Liu X; Niu Y; Lu JJ; Chen X
    Ann N Y Acad Sci; 2017 Aug; 1401(1):19-27. PubMed ID: 28891091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
    Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
    Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrosion-Activated Chemotherapeutic Function of Nanoparticulate Platinum as a Cisplatin Resistance-Overcoming Prodrug with Limited Autophagy Induction.
    Cheng HJ; Wu TH; Chien CT; Tu HW; Cha TS; Lin SY
    Small; 2016 Nov; 12(44):6124-6133. PubMed ID: 27717137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms for tumour resistance to chemotherapy.
    Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
    Sun H; Yarovoy I; Capeling M; Cheng C
    Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells.
    Owen S; Zhao H; Dart A; Wang Y; Ruge F; Gao Y; Wei C; Wu Y; Jiang WG
    Int J Oncol; 2016 Nov; 49(5):1839-1847. PubMed ID: 27600495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge.
    Yousefi B; Zarghami N; Samadi N; Majidinia M
    Anticancer Agents Med Chem; 2016; 16(12):1541-1548. PubMed ID: 26845135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating ROS to overcome multidrug resistance in cancer.
    Cui Q; Wang JQ; Assaraf YG; Ren L; Gupta P; Wei L; Ashby CR; Yang DH; Chen ZS
    Drug Resist Updat; 2018 Nov; 41():1-25. PubMed ID: 30471641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells.
    Aksenov AV; Smirnov AN; Magedov IV; Reisenauer MR; Aksenov NA; Aksenova IV; Pendleton AL; Nguyen G; Johnston RK; Rubin M; De Carvalho A; Kiss R; Mathieu V; Lefranc F; Correa J; Cavazos DA; Brenner AJ; Bryan BA; Rogelj S; Kornienko A; Frolova LV
    J Med Chem; 2015 Mar; 58(5):2206-20. PubMed ID: 25671501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.